Others

Bal Pharma Ltd. - Board to consider Dividend

| Updated on April 03, 2019 Published on April 03, 2019

Bal Pharma Ltd has informed BSE that the meeting of Board of Directors of the Company is scheduled to be held on May 29, 2019.

The Board of Directors inter alia will be considering :

1. Approval of Audited Stand Alone and Consolidated financial results of the Company for the quarter and year ended March 31, 2019.

2. Appropriation of profits including recommendation of dividend, if any, for the financial year 2018-19.

Further, pursuant to amended provisions of SEBI (Prohibition of Insider Trading Regulations), 2015 and as per the provisions of Code of Conduct of the Company, the trading window for dealing in securities of the Company by its designated persons/ employees and their immediate relatives will remain closed from April 02, 2019 up to May 31, 2019 i.e. 48 hours after
declaration of financial results for the financial year ended March 31, 2019.

Pdf Link: Bal Pharma Ltd. - Board to consider Dividend

Source : BSE - www.bseindia.com

Published on April 03, 2019
This article is closed for comments.
Please Email the Editor